Position in DYN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,336,175
+$810,100 QoQ
Shares Held
60,161
+44.7% QoQ
Ownership
0.032%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#109
of 245 holders
Holding Since
Dec 2020
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DYN Over Time
Shares Held
Position Value (USD)
Derivatives in DYN
reported options exposure · as of Mar 31, 2024CallValue
$1,419,500
CallShares
50,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026D. E. Shaw & Co., Inc. holds $5,017,559,982 across 217 Biotechnology names. DYN ranks #146 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
5,877,959 | $626,707,987 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,104,109 | $332,369,932 | |
| 3 | EXEL |
Exelixis, Inc.
|
5,551,747 | $302,070,554 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
3,633,007 | $270,586,360 | |
| 5 | TGTX |
Tg Therapeutics, Inc.
|
3,400,808 | $186,840,390 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
2,006,479 | $157,047,110 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
604,753 | $148,025,391 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
1,548,919 | $126,345,322 |
All Filings in DYN
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,336,175 | 60,161 | Shares | Defined | 2026-08-14 | |
| 2025-09-30 | $526,075 | 41,587 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $4,845,108 | 508,940 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,008,849 | 287,653 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $3,151,668 | 133,772 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $2,623,596 | 73,040 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $3,120,341 | 88,420 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,419,500 | 50,000 | Call | Defined | 2024-05-15 | |
| 2023-03-31 | $272,655 | 23,668 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $153,521 | 13,246 | Shares | Defined | 2023-02-14 | |
| 2020-12-31 | $215,880 | 10,280 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||